Print Page   |   Contact Us   |   Sign In   |   Join
MichBio U: Major Considerations in Early-Stage Translational Planning
Tell a Friend About This EventTell a Friend
 

2/9/2015
When: February 9, 2015
1:30-2:30 p.m.
Where: Webinar
Presenter: Jon Mirsalis and David Sahner, SRI International
Contact: Dave McGuire
734.527.9150


Online registration is closed.
« Go to Upcoming Event List  

 

 

 

Major Considerations in Early-Stage Translational Planning

 

Members: Free (Membership verified prior to event)

Register here 
 
Nonmembers: $29

Register here (same link as in the 'Registration Information' section above)

 

 

 Are you a company in early R&D or an individual involved in translational planning? 

 

Join us for this informative webinar, presented by SRI International, where we'll discuss key development questions and considerations for companies in the early R&D stages that affect the likelihood of getting to critical value inflection points that enable late-phase clinical development or out-licensing. 

We will provide an overview of the IND process and review specific tactics and strategies. Takeaways will include the benefits of such planning: 

  • Increased efficiency
  • Reduced risk
  • Reduced cost
  • Greater chances of bringing a significant product to market

Presenters: 

 

 

 

Jon C. Mirsalis, PhD, DABT 
Managing Director, Biosciences Division & Executive Director, Translational Development 
SRI International 

David Sahner, MD 
Senior Director, Clinical Translation 
SRI International

 

 

 

MichBio U is generously supported by Bank of America Merrill Lynch.

 

Learn more about MichBio U.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership.com®  ::  Legal